CSIMarket Company Name, Ticker, Competitors, else..
 
Gri Bio Inc   (NASDAQ: GRI)
 

Gri Bio Inc's Suppliers Performance

GRI's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
GRI Costs vs Sales of Suppliers Growth

• More on GRI Suppliers






Gri Bio Inc's Comment on Supply Chain


The company relies on contract manufacturers to produce GRI-0621 for preclinical studies and clinical trials and does not own manufacturing facilities. It depends on a limited number of suppliers for the drug product and uses a single manufacturer to produce the formulated GRI-0621 drug product for clinical studies. If these suppliers fail to meet supply obligations, the company may encounter difficulties securing alternative supplies on acceptable terms or in a timely manner. Changing manufacturers requires verification that the new manufacturer complies with quality standards and regulations and that the product meets previously submitted specifications, which may necessitate additional clinical trials and cause development delays.

Gri Bio Inc's Comment on Supply Chain


The company relies on contract manufacturers to produce GRI-0621 for preclinical studies and clinical trials and does not own manufacturing facilities. It depends on a limited number of suppliers for the drug product and uses a single manufacturer to produce the formulated GRI-0621 drug product for clinical studies. If these suppliers fail to meet supply obligations, the company may encounter difficulties securing alternative supplies on acceptable terms or in a timely manner. Changing manufacturers requires verification that the new manufacturer complies with quality standards and regulations and that the product meets previously submitted specifications, which may necessitate additional clinical trials and cause development delays.







GRI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Gri Bio Inc 3.50 0.00 -9.66 4
SUBTOTAL 0.00 0.00 0.00 -


Sources: Gri Bio Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Gri Bio Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.